The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the third quarter of 2025 of $0.22 per Class A ordinary share. The dividend will be paid on ...

The cross-asset moves come at the end of a week marked by market jitters over speculation that President Donald Trump might ...